$CNC

2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation

Centene Corp. (CNC) and Archer-Daniels-Midland Co. (ADM) are highlighted for strong performance and attractive valuations. CNC expects 2026 revenues of $173-$177B and adjusted EPS over $4.80, with a forward P/E of 13.58X. ADM raised 2026 adjusted earnings guidance to $5.15-$5.60 per share, with a forward P/E of 16.60X.

Original reporting
Published Sep 15, 2026, 12:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 4:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation — source image
Decision brief

The 30-second read

$CNCBullishMed
01

Why it matters

New guidance lifts earnings expectations, which could drive price appreciation, but investors should monitor policy and commodity risks.

02

Market read

Guidance upgrades for CNC and ADM provide fresh material for traders seeking upside in healthcare and agribusiness sectors.

03

What to watch

Potential headwinds from Medicaid policy changes and commodity price volatility could temper gains.

Relevance 7/10Novelty 7/10Timing: guidance update released today

Background

The article highlights two non‑AI stocks with strong Zacks Rank #1 and updated 2026 guidance, positioning them as attractive buys for the remainder of the year.

Company-level read

Ticker impact

$CNCBullishHigh confidence
Context

Centene Corp. raised its 2026 revenue guidance to $173‑$177 B and adjusted EPS to >$4.80, a fresh update disclosed in this article.

Expected impact

Potential upside of 5‑10% over the next weeks if market digests the guidance.

Evidence & confidence

Guidance beats prior expectations and EPS outlook improves >130%, indicating strong upside.

$ADMBullishHigh confidence
Context

Archer‑Daniels‑Midland announced 2026 adjusted earnings guidance of $5.15‑$5.60 per share, up from $4.15‑$4.70, a new disclosure.

Expected impact

Expect modest rally of 3‑7% as investors price in higher earnings.

Evidence & confidence

Guidance increase reflects better margins from renewable fuel obligations and higher energy prices.

Market effects

Both healthcare and agribusiness sectors may see uplift as peers' guidance improves.

U.S. markets could see modest gains in related ETFs tracking health services and commodities.

Positive guidance may reinforce confidence in AI‑linked growth themes globally.

Counterpoint

If guidance improvements are already priced in, the stocks may face limited upside.

Key entities

  • Centene Corp.

    U.S. healthcare services provider

  • Archer‑Daniels‑Midland Co.

    U.S. agribusiness and food processing company

Related articles

$CNCMedAI 8/10

Centene Corp (CNC) (Q3 2026) Earnings Call Highlights: Raised Guidance and Medicare

Centene Corp (CNC) reported Q3 2026 earnings, raising guidance. Medicaid membership is expected to decline 8-9% YoY by 2026 end, with further attrition in 2027. Medicare Advantage membership may drop YoY in 2027. PDP pretax margin is forecasted to reset lower in 2027, initially at 2-3%. CEO Sarah London addressed market contraction expectations and cost-saving measures during the earnings call.

$CNCMedAI 8/10

What Centene (CNC) Said on Its Q3 Earnings Call

Centene (CNC) reported Q3 earnings, highlighting strong Medicare segment performance with a 93.8% HBR. The company raised its 2026 pre-tax margin forecast for PDP to mid-to-high 3% and expects Medicare Advantage break-even in 2026. Marketplace margins are improving, with a full-year 2026 pre-tax margin expected at the top of the 4.5%-5% range. Centene reduced debt to $15.0B and expects adjusted EPS growth in 2027.

$CNCHighAI 8/10

Centene (CNC) Q3 2026 Earnings Call Transcript

Centene (CNC) reported Q3 2026 earnings, highlighting a Medicaid HBR of 93.6, up 30 basis points from Q2. The company expects full-year Medicaid HBR of 93.5. Medicaid membership was in line with expectations, with a projected 8-9% year-end decline. Medicare Advantage and standalone Part D performed well, with Medicare Advantage on track for 2026 breakeven. Marketplace business is expected to produce a full-year pretax margin at the top of the 4.5% to 5.0% range.

$CNCMed

Centene Corporation Q3 2026 Earnings Call Summary

Centene Corporation reported Q3 2026 earnings, highlighting Medicare Advantage breakeven, Medicaid stability, and Marketplace margin recovery. The company reduced debt to $15.0 billion and expects 2027 adjusted EPS growth. Management plans to exit less profitable areas and optimize costs. Medicaid membership is declining, and Marketplace enrollment may contract in 2027. Non-recurring benefits added $0.50 per share in 2026.

$CNCMed

Centene progresses on profit recovery, drops 6,000 employees

Centene reported Q3 revenue of $50.6B, up 2% YoY, and narrowed losses to $71M. The company raised its 2026 earnings outlook due to Medicare Advantage cost reductions, now expecting to break even in the segment. Centene also announced layoffs and voluntary separations, reducing its workforce by 6,000 employees, which is expected to improve margins in 2027. The company's medical loss ratio was 92.7%, slightly better than expected.